Skip to main content
. 2016 Mar 18;7:104. doi: 10.3389/fphys.2016.00104

Figure 7.

Figure 7

Rapamycin inhibited cardiac hypertrophy in vivo. (A,B) Whole hearts (A) and H&E staining (B) of normal and aortic banding (AB) mice at 8 weeks post-surgery in the presence or absence of rapamycin and/or PD98059. (C,D) Western blot analysis of the hypertrophy and autophagy markers ANP, BNP, Beclin-1 and Noxa. *p < 0.05, **p < 0.01, ***p < 0.001 vs. Control. Experiments were repeated three times, n = 3. (E,F) The mRNA expression levels of ANP (F) and BNP (E) in myocardial tissues in each group were measued by Rt-PCR. *p < 0.05, **p < 0.01 vs. Control. (G,H) Measurements of myocardial cross-sectional area and heart weight/body weight ratio in the response to the indicated treatments. n = 8. *p < 0.05, **p < 0.01 vs. Control.